Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4(th) European Conference on Infections in Leukemia (ECIL-4, 2011)

The detection of multi-resistant bacterial pathogens, particularly those to carbapenemases, in leukemic and stem cell transplant patients forces the use of old or non-conventional agents as the only remaining treatment options. These include colistin/polymyxin B, tigecycline, fosfomycin and various...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Averbuch, Diana, Cordonnier, Catherine, Livermore, David M., Mikulska, Małgorzata, Orasch, Christina, Viscoli, Claudio, Gyssens, Inge C., Kern, Winfried V., Klyasova, Galina, Marchetti, Oscar, Engelhard, Dan, Akova, Murat
Formato: Artigo
Lenguaje:Inglês
Publicado: Ferrata Storti Foundation 2013
Materias:
Guideline Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3856958/
https://ncbi.nlm.nih.gov/pubmed/24323984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.091330
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares